Search research articles
Contact Us
Filters
Showing results (1-10 of 155) with videos related to
Page
of 16
Sort By:
Digestion
|
September 11, 2023
Current Treatment Practices for Adult Patients with Constipation in Japan
Takaomi Kessoku, Noboru Misawa, Hidenori Ohkubo, et al.
Diabetology International
|
January 4, 2019
Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study
Tomoyuki Iwasaki, Takaomi Kessoku, Takuma Higurashi, et al.
Journal of Palliative Medicine
|
April 10, 2026
Cost-Effectiveness of Prophylactic Naldemedine for Opioid-Induced Constipation in Patients with Cancer
Reiko Okubo, Takahiro Higashibata, Masahide Kondo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 28, 2025
Establishing the minimal important change for Patient Assessment of Constipation Quality of Life questionnaire for the prevention of opioid-induced constipation in patients with cancer pain
Takahiro Higashibata, Shunsuke Oyamada, Jun Hamano, et al.
Expert Opinion on Pharmacotherapy
|
November 10, 2018
Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults
Yuji Ogawa, Masato Yoneda, Takashi Kobayashi, et al.
Japanese Journal of Clinical Oncology
|
October 2, 2024
Effect of add-on naldemedine treatment in patients with cancer and opioid-induced constipation insufficiently responding to magnesium oxide: a pooled, subgroup analysis of two randomized controlled trials
Takaomi Kessoku, Toshikazu Akamatsu, Yasuhide Morioka, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
October 10, 2018
[Gut microbiota and nonalcoholic steatohepatitis]
Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, et al.
Expert Opinion on Emerging Drugs
|
July 16, 2013
Emerging drugs for non-alcoholic steatohepatitis
Wataru Tomeno, Masato Yoneda, Kento Imajo, et al.
Cureus
|
April 11, 2024
Naldemedine and Magnesium Oxide as First-Line Medications for Opioid-Induced Constipation: A Comparative Database Study in Japanese Patients With Cancer Pain
Takaomi Kessoku, Takahiro Higashibata, Yasuhide Morioka, et al.
Biomed Research International
|
January 14, 2020
Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression
Yuka Murata, Takashi Yamashiro, Takaomi Kessoku, et al.
Page
of 16
Search research articles
Search
Showing results (1-10 of 155) with videos related to
Sort By:
Page
of 16
Digestion
|
September 11, 2023
Current Treatment Practices for Adult Patients with Constipation in Japan
Takaomi Kessoku, Noboru Misawa, Hidenori Ohkubo, et al.
Diabetology International
|
January 4, 2019
Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study
Tomoyuki Iwasaki, Takaomi Kessoku, Takuma Higurashi, et al.
Journal of Palliative Medicine
|
April 10, 2026
Cost-Effectiveness of Prophylactic Naldemedine for Opioid-Induced Constipation in Patients with Cancer
Reiko Okubo, Takahiro Higashibata, Masahide Kondo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 28, 2025
Establishing the minimal important change for Patient Assessment of Constipation Quality of Life questionnaire for the prevention of opioid-induced constipation in patients with cancer pain
Takahiro Higashibata, Shunsuke Oyamada, Jun Hamano, et al.
Expert Opinion on Pharmacotherapy
|
November 10, 2018
Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults
Yuji Ogawa, Masato Yoneda, Takashi Kobayashi, et al.
Japanese Journal of Clinical Oncology
|
October 2, 2024
Effect of add-on naldemedine treatment in patients with cancer and opioid-induced constipation insufficiently responding to magnesium oxide: a pooled, subgroup analysis of two randomized controlled trials
Takaomi Kessoku, Toshikazu Akamatsu, Yasuhide Morioka, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
October 10, 2018
[Gut microbiota and nonalcoholic steatohepatitis]
Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, et al.
Expert Opinion on Emerging Drugs
|
July 16, 2013
Emerging drugs for non-alcoholic steatohepatitis
Wataru Tomeno, Masato Yoneda, Kento Imajo, et al.
Cureus
|
April 11, 2024
Naldemedine and Magnesium Oxide as First-Line Medications for Opioid-Induced Constipation: A Comparative Database Study in Japanese Patients With Cancer Pain
Takaomi Kessoku, Takahiro Higashibata, Yasuhide Morioka, et al.
Biomed Research International
|
January 14, 2020
Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression
Yuka Murata, Takashi Yamashiro, Takaomi Kessoku, et al.
Page
of 16